Ethics declarations Competing interests SHI is the CEO of ImmunoBiome but declares no conflicts of interest for this paper
Preliminary data suggest potential anti-inflammatory effects, but these findings require further validation
Back Moody, AJ, Holst, JJ, Thim, L, Lindkaer Jensen, S (5 Feb 1981) 'Relationship of glicentin to proglucagon and glucagon in the porcine pancreas', Nature , 289, 514-16
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
PlexusDx delivers compounded GLP-1 medications directly to patients without requiring insurance, membership fees, or lengthy authorization processes, making precision weight loss therapy more affordable and available than ever before
Obesity and GLP-1